A comparison of insulin suppression tests performed with somatostatin and octreotide with particular reference to tolerability.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Diabetes Research and Clinical Practice

• Publication date

  2001-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0168-8227(00)00238-2PMID 11269891
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Relationship between several surrogate estimates of insulin resistance and quantification of insulin-mediated glucose disposal in 490 healthy nondiabetic volunteers.

  2000cited by this paper
• Report of the expert committee on the diagnosis and classification of diabetes mellitus.

  1999cited by this paper
• Growth hormone (GH) replacement reduces total body fat and normalizes insulin sensitivity in GH-deficient adults: a report of one-year clinical experience.

  1997cited by this paper
• Growth hormone (GH) replacement reduces total body fat and normalizes insulin sensitivity in GH-deficient adults: a report of one-year clinical experience.

  1997cited by this paper
• Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus

  1997cited by this paper
• Modified method using a somatostatin analogue, octreotide acetate (Sandostatin) to assess in vivo insulin sensitivity.

  1996cited by this paper
• Octreotide: a long-acting inhibitor of endogenous hormone secretion for human metabolic investigations.

  1994influential reference
• Evaluation of octreotide to assess insulin-mediated glucose disposal by the insulin suppression test

  1994cited by this paper
• Insulin Sensitivity Test Using a Somatostatin Analogue, Octreotide (Sandostatin®)

  1994cited by this paper
• How to measure insulin action in vivo.

  1994cited by this paper
• Reproducibility of the measurement of insulin sensitivity by the modified insulin suppression test.

  1992cited by this paper
• Somatostatin in acute bleeding oesophageal varices. Pharmacology and rationale for use.

  1992cited by this paper
• Insulin Resistance: A Multifaceted Syndrome Responsible for NIDDM, Obesity, Hypertension, Dyslipidemia, and Atherosclerotic Cardiovascular Disease

  1991cited by this paper
• Insulin Insensitivity in Offspring of Parents with Type 2 Diabetes Mellitus

  1990cited by this paper
• Octreotide

  1989cited by this paper
• The effect of somatostatin on central hemodynamics, renal blood flow, and renal function in dogs.

  1985cited by this paper
• Statistical Methods in the Biological and Health Sciences

  1982cited by this paper
• SMS 201-995: a very potent and selective octapeptide analogue of somatostatin with prolonged action.

  1982cited by this paper
• Systemic and pulmonary haemodynamic effects of somatostatin.

  1981cited by this paper
• Assessment of Insulin Resistance with the Insulin Suppression Test and the Euglycemic Clamp

  1981cited by this paper
• Glucose clamp technique: a method for quantifying insulin secretion and resistance.

  1979cited by this paper
• Glucose, insulin and somatostatin infusion for the determination of insulin sensitivity.

  1977cited by this paper
• The Banting Memorial Lecture 1975: Diabetes and the Alpha Cell

  1976cited by this paper
• Comparison of impedance to insulin-mediated glucose uptake in normal subjects and in subjects with latent diabetes.

  1970cited by this paper

• Insulin and the Physiology of Carbohydrate Metabolism

  2011cites this paper
• Measurement of C-peptide concentrations and responses to somatostatin, glucose infusion, and insulin resistance in horses.

  2010cites this paper
• Effects of prior exercise on insulin-mediated and noninsulin-mediated glucose uptake in horses during a hyperglycaemic clamp.

  2010cites this paper
• Prehypertension is associated with insulin resistance.

  2009cites this paper
• Differences in height explain gender differences in the response to the oral glucose tolerance test— the AusDiab study

  2008cites this paper
• Surrogate estimates of insulin sensitivity in subjects with hypertension

  2007cites this paper
• Directly measured insulin resistance and the assessment of clustered cardiovascular risks in hypertension.

  2006cites this paper
• Should we routinely measure a proxy for insulin resistance as well as improve our modelling techniques to better predict the likelihood of coronary heart disease in people with type 2 diabetes? For debate

  2004cites this paper
• Exacerbation of insulin resistance and postprandial triglyceride response in newly diagnosed hypertensive patients with hypertriglyceridaemia

  2002cites this paper
• Refereed Papers Included in Science Citation Index

  2001cites this paper